Axion Biosystems Maestro Pro Microelectrode Array (Mea) System – Brand Name or Equal

This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with Federal Acquisition Regulation (FAR) Part 12, as implemented through the Revolutionary FAR Overhaul (RFO) model deviation and applicable Department of Health and Human Services (HHS) class deviations. This announcement constitutes solicitation. Quotations are being requested, and a separate written solicitation will not be issued. Solicitation No. CBER-2026-135659 is issued as a Request for Quotation (RFQ) for the purchase of an Axion BioSystems Maestro Pro Microelectrode Array (MEA) System, brand name or equal, together with the required software, consumables, installation, training, warranty, and an option for preventive maintenance. This acquisition is not set aside for small business concerns and is being competed on an unrestricted basis. The Government intends to issue a Firm-Fixed-Price purchase order using simplified procedures for commercial products and commercial services under RFO FAR Part 12. Please refer to the Combined Synopsis-Solicitation Maestro Pro Microelectrode Array System Document and all the attachments for specfic details about the requirement

• NAICS334516
• PSC6640

• Combined Synopsis-Solicitation Maestro Pro Microelectrode Array System Document.docx

  .docx56 KBNot yet available
• Attachment 5 CountryofOrigin and Trade Agreements Certificate.docx

  .docx27 KBNot yet available
• Attachent 1 SOW.docx

  .docx37 KBNot yet available
• Attachment 3 Technical Compliance Matrix.docx

  .docx36 KBNot yet available
• Attachment 6 - MANDATORY ITEM-BY-ITEM COUNTRY-OF-ORIGIN AND PLACE-OF-MANUFACTURE DISCLOSURE.xlsx

  .xlsx11 KBNot yet available
• Attachment 4 Past Performance Reference Form.docx

  .docx31 KBNot yet available
• Attachment 2 - Pricing Spreadsheet.xlsx

  .xlsx18 KBNot yet available

• Michele Jackson
  michele.jackson@fda.hhs.gov